Askbio France, Sas, A Subsidiary Of Askbio Inc.

This early-stage trial tests a gene therapy called AB-1001, injected directly into the brain, in 5 adults with early Huntington's disease. The main goal is to check safety and side effects, while also looking at brain changes on MRI. It is not a cure, but aims to slow or control …